RE-BVS – Piemonte Repository

Sfoglia per AUTORE
CALDARA A
Collezione AOU Città della Salute di Torino

Items : 4

Author Correction: Real-world ANASTASE study of atezolizumab+nab-paclitaxel as first-line treatment of PD-L1-positive metastatic triple-negative breast cancer. in NPJ breast cancer / NPJ Breast Cancer. 2024 Feb 5;10(1):13. doi: 10.1038/s41523-024-00619-5.

2024
AOU Città della Salute di Torino

Caldara A; Fontana A; Haspinger ER; Verderame F; Franco A; Valerio MR; Beano A; Raffaele M; Criscitiello C; Curigliano G; Guarino S; Pedersini R; Strina C; La Verde N; Savastano MC; Fuso P; Paris I; Botticelli A; Carbognin L; Fabi A; Di Leone A; Tortora G; Giannarelli D; Scambia G;

Real-world ANASTASE study of atezolizumab+nab-paclitaxel as first-line treatment of PD-L1-positive metastatic triple-negative breast cancer. in NPJ breast cancer / NPJ Breast Cancer. 2023 Sep 8;9(1):73. doi: 10.1038/s41523-023-00579-2.

2023
AOU Città della Salute di Torino

Fabi A; Carbognin L; Botticelli A; Paris I; Fuso P; Savastano MC; La Verde N; Strina C; Pedersini R; Guarino S; Curigliano G; Criscitiello C; Raffaele M; Beano A; Franco A; Valerio MR; Verderame F; Fontana A; Haspinger ER; Caldara A; Di Leone A; Tortora G; Giannarelli D; Scambia G;

2023
AOU Città della Salute di Torino

A randomized, phase 2 study of cetuximab plus cisplatin with or without paclitaxel for the first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2017 Nov 1;28(11):2820-2826. doi: 10.1093/annonc/mdx439.

2017
AOU Città della Salute di Torino

Bossi P; Miceli R; Locati LD; Ferrari D; Vecchio S; Moretti G; Denaro N; Caponigro F; Airoldi M; Moro C; Vaccher E; Sponghini A; Caldara A; Rinaldi G; Ferrau F; Nolè F; Lo Vullo S; Tettamanzi F; Hollander L; Licitra L;